Cargando…

Nivolumab-Induced Concomitant Severe Upper and Lower Gastrointestinal Immune-Related Adverse Effects

Immunotherapy agents such as cytotoxic T-lymphocyte antigen-4 and programed cell death protein-1 inhibitors show efficacy in cancer therapy but are associated with immune-related adverse events. It commonly presents as diarrhea but can cause colitis, mimicking inflammatory bowel disease. Our patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhatem, Albert, Patel, Krishan, Eriksen, Brenda, Bukhari, Sarosh, Liu, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145206/ https://www.ncbi.nlm.nih.gov/pubmed/32309466 http://dx.doi.org/10.14309/crj.0000000000000249

Ejemplares similares

Immune-related adverse events and prognosis in patients with upper gastrointestinal cancer treated with nivolumab
por: Hara, Yoshihiro, et al.
Publicado: (2022)

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
por: Zhou, Shi, et al.
Publicado: (2019)

Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis
por: Fukasawa, Yoko, et al.
Publicado: (2017)

Rare Adverse Events Related to Nivolumab, an Immune Checkpoint Inhibitor: A Case Series
por: Ganta, Nagapratap, et al.
Publicado: (2022)

Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer
por: Higashi, Tetsuo, et al.
Publicado: (2020)

Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies
por: Les, Iñigo, et al.
Publicado: (2021)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Upper and/or lower gastrointestinal adverse events with glucagon‐like peptide‐1 receptor agonists: Incidence and consequences
por: Horowitz, Michael, et al.
Publicado: (2017)

Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021)

Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events
por: Imafuku, Keisuke, et al.
Publicado: (2017)

Severe eosinophilia and subsequent dermatologic immune‐related adverse event with squamous cell carcinoma antigen elevation induced by nivolumab and ipilimumab
por: Matsumoto, Takeshi, et al.
Publicado: (2022)

Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism
por: Kobayashi, Mizuki, et al.
Publicado: (2022)

Concomitant Human Herpes Virus 6 and nivolumab-related pneumonitis: Potential pathogenetic insights
por: Foukas, Periklis G., et al.
Publicado: (2018)

Xanthogranulomatous Pyelonephritis: Synchronous Upper and Lower Gastrointestinal Bleed
por: Mirza, Muhammad Usman, et al.
Publicado: (2019)

The Role of Microbiota in Upper and Lower Gastrointestinal Functional Disorders
por: Mandarino, Francesco Vito, et al.
Publicado: (2023)

Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab
por: Yamauchi, Ichiro, et al.
Publicado: (2019)

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
por: Masuda, Ken, et al.
Publicado: (2019)

Gastrointestinal disorders as immune-related adverse events
por: Balducci, Daniele, et al.
Publicado: (2021)

Immune-Related Adverse Events of the Gastrointestinal System
por: Nicolaides, Steven, et al.
Publicado: (2023)

Two-stage surgery for delayed esophageal perforation and concomitant chylothorax secondary to upper gastrointestinal endoscopy
por: Chaudhry, Ikram ul Haq, et al.
Publicado: (2022)

The Clinical Outcomes of Lower Gastrointestinal Bleeding Are Not Better than Those of Upper Gastrointestinal Bleeding
por: Kwak, Min Seob, et al.
Publicado: (2016)

SUN-414 Immune Related Adverse Events: Isolated ACTH Deficiency with Nivolumab/Ipilimumab Combination Therapy
por: Magdaleno, Angela, et al.
Publicado: (2019)

Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab
por: Mizutani, Kosuke, et al.
Publicado: (2021)

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
por: Yoneda, Hiroto, et al.
Publicado: (2021)

Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab
por: Sawada, Ryo, et al.
Publicado: (2021)

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
por: Meagher, Nicola S., et al.
Publicado: (2022)

Upper Gastrointestinal Hemorrhage: Validation of the Severity Score
por: Chaikitamnuaychok, Rangson, et al.
Publicado: (2013)

Upper Gastrointestinal Hemorrhage: Development of the Severity Score
por: Chaikitamnuaychok, Rangson, et al.
Publicado: (2012)

Editorial: Gastrointestinal cancer immune response and immune related adverse effects
por: Wen, Ti, et al.
Publicado: (2022)

Adverse events induced by nivolumab and ipilimumab combination regimens
por: Somekawa, Kohei, et al.
Publicado: (2022)

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook
por: Möhn, Nora, et al.
Publicado: (2019)

A case with hepatic immune-related adverse events caused by nivolumab exhibiting impaired accumulation of regulatory T cells
por: Sekai, Ikue, et al.
Publicado: (2021)

Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
por: Sostres, Carlos, et al.
Publicado: (2013)

Synchronous Upper and Lower Gastrointestinal Mucosa-Associated Lymphoid Tissue Lymphomas
por: McFarlane, Michael, et al.
Publicado: (2016)

Procalcitionin as a diagnostic marker to distinguish upper and lower gastrointestinal perforation
por: Gao, Yang, et al.
Publicado: (2017)

Heparin/warfarin: Upper and lower gastrointestinal bleeding: 2 case reports
Publicado: (2020)

Enoxaparin-sodium: Upper and lower gastrointestinal bleeding: 3 case reports
Publicado: (2021)

Nivolumab: Immune-related meningoencephalitis: case report
Publicado: (2021)

Nivolumab and immune‐mediated colitis
por: Walker, Heather, et al.
Publicado: (2019)

Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding
por: Wang, Qing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qt11t84mjgnkbkodvhpodmvvc2